KOL Lunch: Unmet Medical Need in the Treatment of nOH, hosted by Theravance Biopharma (TBPH)

The event will feature a presentation by key opinion leader Roy Freeman, MB ChB (Harvard Medical School, Beth Israel Deaconess Medical Center), who will discuss the current treatment landscape and unmet medical need for treating patients with neurogenic orthostatic hypotension (nOH).